Emerging Biotech
Brii Biosciences Unveils Dual-Targeting siRNA Platform to Advance Next-Generation RNA Therapeutics
Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines Initial focus on prevalent me...
October 19, 2026 | News
Jyong Biotech Eyes Texas Manufacturing Hub to Accelerate US Market Expansion
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commerc...
October 19, 2026 | News
China’s Hiteck Biological Pharma Licenses Next-Generation Eye Therapy to Visara for Global Development
Wuhan Hiteck Biological Pharma Co., Ltd. announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc...
October 15, 2026 | News
Nuevocor Doses First Patient in Phase 1/2 Gene Therapy Trial for Inherited Cardiomyopathy
Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening...
October 13, 2026 | News
GenScript and NVIDIA Launch Global PitchFest to Accelerate AI-Driven Drug Discovery Startups
GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying arti...
October 12, 2026 | News
XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery
This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...
October 08, 2026 | News
EpiSign, Geneyx Partner to Integrate Genomic and Epigenomic Analysis for Rare Diseases
Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform EpiS...
October 07, 2026 | News
Bambusa Doses First Patient in Subcutaneous Cohort of Phase I BBT001 Trial
First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration ...
October 05, 2026 | News
XtalPi-Backed Viva-Thera Advances AI-Designed HIV Candidate to Preclinical Stage in Seven Months
Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. Viva-Th...
September 24, 2026 | News
CelluPro Becomes First Chinese Cell Culture Media Supplier to Secure EXCiPACT GMP Certification
CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certif...
September 09, 2026 | News
Rznomics Advances High-Efficiency Circular RNA Production with Engineered STS Technology
Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in t...
September 08, 2026 | News
AstraZeneca Secures US FDA Approval for ETCAMAH Combination in Advanced Breast Cancer
Approval based on SERENA-6 Phase III trial results which showed combination reduced the risk of disease progression or death by 56% in patients with an e...
September 08, 2026 | News
Novonesis Invests €600M to Expand Enzyme Production Facility in India
Novonesis will expand its facility in Patalganga and build one of the world's most advanced enzyme production facilities. The €600 million investment ...
September 07, 2026 | News
DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours
Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...
August 31, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
